Literature DB >> 27158595

Bioengineering novel floating nanoparticles for protein and drug delivery.

Priya DasSarma1, Ram Karan1, Jong-Myoung Kim2, Wolf Pecher3, Shiladitya DasSarma1.   

Abstract

Gas vesicle nanoparticles (GVNPs) are hollow protein nanoparticles produced by Halobacterium sp. NRC-1 which are being engineered for protein delivery. To advance the bioengineering potential of GVNPs, a strain of NRC-1 deleted for the gvpC gene (ΔgvpC) was constructed and a synthetic gene coding for Gaussia princeps luciferase was fused to an abbreviated gvpC gene on an expression plasmid. When introduced into theΔgvpC strain, an active GvpC-luciferase fusion protein bound to GVNPs resulted. These results represent both a technical improvement in the GVNP display system and its expansion for the display of active enzymes.

Entities:  

Keywords:  Gas vesicle naoparticles (GVNPs); Gaussia princeps; enzyme display; luciferase; vaccine

Year:  2016        PMID: 27158595      PMCID: PMC4856160          DOI: 10.1016/j.matpr.2016.01.058

Source DB:  PubMed          Journal:  Mater Today Proc        ISSN: 2214-7853


  18 in total

1.  Antigen presentation using novel particulate organelles from halophilic archaea.

Authors:  E S Stuart; F Morshed; M Sremac; S DasSarma
Journal:  J Biotechnol       Date:  2001-06-15       Impact factor: 3.307

2.  Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria.

Authors:  Priya DasSarma; Vidya Devi Negi; Arjun Balakrishnan; Ram Karan; Susan Barnes; Folasade Ekulona; Dipshikha Chakravortty; Shiladitya DasSarma
Journal:  Vaccine       Date:  2014-06-17       Impact factor: 3.641

3.  Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigens as a novel approach to vaccine development.

Authors:  P DasSarma; V D Negi; A Balakrishnan; J-M Kim; R Karan; D Chakravortty; S DasSarma
Journal:  Procedia Vaccinol       Date:  2015

4.  Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea.

Authors:  Elizabeth S Stuart; Fazeela Morshed; Marinko Sremac; Shiladitya DasSarma
Journal:  J Biotechnol       Date:  2004-11-09       Impact factor: 3.307

5.  In vitro assessment of halobacterial gas vesicles as a Chlamydia vaccine display and delivery system.

Authors:  Tawanna S Childs; Wilmore C Webley
Journal:  Vaccine       Date:  2012-07-28       Impact factor: 3.641

6.  Bioengineering radioresistance by overproduction of RPA, a mammalian-type single-stranded DNA-binding protein, in a halophilic archaeon.

Authors:  Ram Karan; Priya DasSarma; Elizabeth Balcer-Kubiczek; Rueyhung Roc Weng; Chen-Chung Liao; David R Goodlett; Wailap Victor Ng; Shiladitya Dassarma
Journal:  Appl Microbiol Biotechnol       Date:  2013-11-29       Impact factor: 4.813

7.  Structure and organization of the gas vesicle gene cluster on the Halobacterium halobium plasmid pNRC100.

Authors:  J G Jones; D C Young; S DasSarma
Journal:  Gene       Date:  1991-06-15       Impact factor: 3.688

8.  Complexity of gas vesicle biogenesis in Halobacterium sp. strain NRC-1: identification of five new proteins.

Authors:  Hem Dutt Shukla; Shiladitya DasSarma
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

9.  An improved genetic system for bioengineering buoyant gas vesicle nanoparticles from Haloarchaea.

Authors:  Shiladitya DasSarma; Ram Karan; Priya DasSarma; Susan Barnes; Folasade Ekulona; Barbara Smith
Journal:  BMC Biotechnol       Date:  2013-12-21       Impact factor: 2.563

10.  Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle.

Authors:  Marinko Sremac; Elizabeth S Stuart
Journal:  BMC Biotechnol       Date:  2008-01-31       Impact factor: 2.563

View more
  1 in total

Review 1.  Microbial gas vesicles as nanotechnology tools: exploiting intracellular organelles for translational utility in biotechnology, medicine and the environment.

Authors:  Amy M Hill; George P C Salmond
Journal:  Microbiology (Reading)       Date:  2020-06       Impact factor: 2.777

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.